Literature DB >> 33493317

Leveraging Vaccines to Reduce Antibiotic Use and Prevent Antimicrobial Resistance: a WHO Action Framework.

Johan Vekemans1, Mateusz Hasso-Agopsowicz1, Gagandeep Kang2, William P Hausdorff3,4, Anthony Fiore5, Elizabeth Tayler1, Elizabeth J Klemm6, Ramanan Laxminarayan7, Padmini Srikantiah8, Martin Friede1, Marc Lipsitch9.   

Abstract

The growing burden of antimicrobial-resistant (AMR) microbes constitutes a significant global threat. Vaccines are effective tools to prevent infections could help to control and prevent AMR. In this Viewpoint we present an Action Framework for vaccines to contribute fully, sustainably and equitably to the prevention and control of AMR by preventing infections and reducing antimicrobial use. The document identifies a series of priority actions in three areas: expanding the use of licensed vaccines to maximize impact on AMR, developing new vaccines that contribute to the prevention and control of AMR, and expanding and sharing knowledge about the impact of vaccines on AMR. The objective of this document is to support an alignment of activities among international vaccine and AMR partners, and structure and articulate key priority actions.
© The Author(s) 2021. Published by Oxford University Press for the Infectious Diseases Society of America.

Entities:  

Keywords:  AMR; Vaccines; WHO

Year:  2021        PMID: 33493317     DOI: 10.1093/cid/ciab062

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  12 in total

Review 1.  A bottom-up view of antimicrobial resistance transmission in developing countries.

Authors:  Odion O Ikhimiukor; Erkison Ewomazino Odih; Pilar Donado-Godoy; Iruka N Okeke
Journal:  Nat Microbiol       Date:  2022-05-30       Impact factor: 30.964

2.  The global burden of sore throat and group A Streptococcus pharyngitis: A systematic review and meta-analysis.

Authors:  Kate M Miller; Jonathan R Carapetis; Chris A Van Beneden; Daniel Cadarette; Jessica N Daw; Hannah C Moore; David E Bloom; Jeffrey W Cannon
Journal:  EClinicalMedicine       Date:  2022-05-20

Review 3.  Resetting the agenda for antibiotic resistance through a health systems perspective.

Authors:  Otto Cars; Sujith J Chandy; Mirfin Mpundu; Arturo Quizhpe Peralta; Anna Zorzet; Anthony D So
Journal:  Lancet Glob Health       Date:  2021-07       Impact factor: 38.927

4.  What Drives the Value of a Shigella Vaccine?

Authors:  William P Hausdorff; Suzanne Scheele; Birgitte K Giersing
Journal:  Vaccines (Basel)       Date:  2022-02-12

5.  Survey among Italian experts on existing vaccines' role in limiting antibiotic resistance.

Authors:  Federico Marchetti; Rosa Prato; Pierluigi Viale
Journal:  Hum Vaccin Immunother       Date:  2021-09-30       Impact factor: 3.452

6.  Prevention of antimicrobial prescribing among infants following maternal vaccination against respiratory syncytial virus.

Authors:  Joseph A Lewnard; Louis F Fries; Iksung Cho; Janice Chen; Ramanan Laxminarayan
Journal:  Proc Natl Acad Sci U S A       Date:  2022-03-14       Impact factor: 11.205

Review 7.  Vaccine Design against Chagas Disease Focused on the Use of Nucleic Acids.

Authors:  Edio Maldonado; Sebastian Morales-Pison; Fabiola Urbina; Aldo Solari
Journal:  Vaccines (Basel)       Date:  2022-04-12

8.  Clinical characteristics, health care resource utilization and direct medical costs of Rotavirus hospitalizations in Spain (2013-2018).

Authors:  Javier Arístegui; Santiago Alfayate-Miguelez; Begoña Carazo-Gallego; Elisa Garrote; Laura Díaz-Munilla; Mikel Mendizabal; María Méndez-Hernández; Elia Doménech; Belén Ferrer-Lorente; María Unsaín-Mancisidor; José Tomás Ramos-Amador; Marta Illán-Ramos; Borja Croche-Santander; Fernando Centeno Malfaz; Julián Rodríguez-Suárez; Manuel Cotarelo Suárez; María San-Martín; Jesús Ruiz-Contreras
Journal:  Hum Vaccin Immunother       Date:  2022-04-18       Impact factor: 4.526

9.  Layered and integrated medical countermeasures against Burkholderia pseudomallei infections in C57BL/6 mice.

Authors:  Christopher P Klimko; Jennifer L Shoe; Nathaniel O Rill; Melissa Hunter; Jennifer L Dankmeyer; Yuli Talyansky; Lindsey K Schmidt; Caitlyn E Orne; David P Fetterer; Sergei S Biryukov; Mary N Burtnick; Paul J Brett; David DeShazer; Christopher K Cote
Journal:  Front Microbiol       Date:  2022-08-17       Impact factor: 6.064

Review 10.  Staphylococcus aureus-A Known Opponent against Host Defense Mechanisms and Vaccine Development-Do We Still Have a Chance to Win?

Authors:  Urszula Wójcik-Bojek; Barbara Różalska; Beata Sadowska
Journal:  Int J Mol Sci       Date:  2022-01-16       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.